Brazil Regulator Says Suspension of Sinovac COVID-19 Vaccine was Technical (Update 1)

“We had no choice but to suspend the trials given the event,” the head of the agency Antônio Barra Torres said at a news conference.

RIO DE JANEIRO, BRAZIL - Brazil’s health regulator Anvisa said on Tuesday, November 10th, that its decision to suspend trials for China’s Sinovac COVID-19 vaccine was purely technical and dismissed any “politicization” of its work to ensure a safe and effective vaccine.

“We had no choice but to suspend the trials given the event,” the head of the agency Antônio Barra Torres said at a news conference. Reuters reported . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?